✦ Turning Vision and Strategy into Results ✦I am a Global Strategy and Operations Executive in Life Sciences, with a demonstrated track record of developing and executing high-impact solutions to address complex/pivotal organizational challenges across the biopharma value chain – including R&D, sales, marketing, manufacturing, regulatory, and quality in Big Pharma, startups, and consulting.The key to my success throughout my career is my disciplined approach to synthesize insights, swiftly identify critical issues, prioritize and execute solutions. I carefully analyze complex problems and engineer impactful solutions based on facts and data. As a respected leader, I empower my teams by providing the tools needed for success while aligning the team’s goals to the company’s vision. I enjoy working hard, producing useful work products, and bringing value to my stakeholders. Notable Accomplishments: Spearheaded project to create a five-year growth plan identifying 50+ opportunities across the business, yielding an annual incremental revenue and cost savings of $400M+.  Led complete asset and portfolio assessment, prioritization, and detailed annual planning at oncology-focused clinical-stage biotech companies with pipelines of assets spanning all phases of development. Synched up valuation and strategic planning to ensure direct impact to enterprise value by operations.  Developed CEO-approved agile launch for Ozempic®, which achieved sales of $3.4B within three years.Brands: Ozempic®, Afinitor®, Zometa®, Femara®, Xolair®, Isentress®, Elelyso®, Liletta®, TOBI®, Qnasl®Specialties include Enterprise-Level Leadership | Strategy | Operations | Enterprise and Asset Valuation | Portfolio Management | Project Management Office | Clinical Program Management | US and Global Product Launches | Budgeting | Turn-around Management | Team Building